Efnb2-flox Mouse
Common Name
Efnb2-flox
제품 ID
S-CKO-02157
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-13642-Efnb2-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Efnb2-flox Mouse (카탈로그 번호 S-CKO-02157)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Efnb2-flox
품종 계통계통 ID
CKOCMP-13642-Efnb2-B6J-VA
유전자명
제품 ID
S-CKO-02157
유전자 별칭
Epl5, ELF-2, Eplg5, Htk-L, Lerk5, LERK-5, NLERK-1
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 8
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000001319
NCBI 전사체 ID
NM_010111
타겟 영역
Exon 2
유효 영역 크기
~2.4 kb
유전자 연구 개요
Efnb2, encoding the transmembrane protein ephrin-B2, is involved in multiple crucial biological functions. It plays a role in cell-to-cell communication pathways, such as the EFNB2-EPHB4 axis which is part of a direct interaction between osteoblasts and osteoclasts, regulating their differentiation and survival, thus contributing to bone homeostasis [1]. Ephrin-B2 also has a role in the assembly of connexin 30 (Cx30) gap junction plaques in the cochlea, and its haploinsufficiency can lead to early disassembly and endocytosis of these plaques, potentially contributing to sensorineural hearing loss [2].
In disease-related research, Efnb2 has been found to be involved in various conditions. In head and neck cancer, it is a key regulator of cetuximab resistance, and targeting it and associated protein-protein interaction circuits might improve treatment response [3]. In colorectal cancer liver metastases, the EFNB2/EPHB4 axis promotes post-metastatic growth via LDLR-mediated cholesterol uptake [4]. In pancreatic ductal adenocarcinoma, EFNB2 promotes cell proliferation, migration, and invasion through the p53/p21 pathway and epithelial-mesenchymal transition (EMT), making it a potential diagnostic and treatment target [6]. In laryngeal squamous cell carcinoma, the mTORC1-ITGA5-EFNB2 signaling pathway is associated with malignant progression and poor prognosis [7]. In intrahepatic cholangiocarcinoma, the Dll4-Notch4-Efnb2 signaling is involved in the differentiation of periportal liver sinusoidal endothelial cells into tip endothelial cells to promote cancer development [8]. Also, EFNB2 potentially protects against intervertebral disc degeneration by inhibiting nucleus pulposus cell apoptosis [5].
In conclusion, Efnb2 is essential for multiple biological processes including cell communication and tissue homeostasis. Its dysregulation is associated with various diseases such as cancers and hearing loss. Studies on Efnb2, especially through gene-knockout or conditional-knockout mouse models in relevant research, have provided valuable insights into its functions in normal and diseased states, highlighting its potential as a therapeutic target for these diseases.
References:
1. Kim, Jung-Min, Lin, Chujiao, Stavre, Zheni, Greenblatt, Matthew B, Shim, Jae-Hyuck. 2020. Osteoblast-Osteoclast Communication and Bone Homeostasis. In Cells, 9, . doi:10.3390/cells9092073. https://pubmed.ncbi.nlm.nih.gov/32927921/
2. Defourny, Jean, Audouard, Christophe, Davy, Alice, Thiry, Marc. 2021. Efnb2 haploinsufficiency induces early gap junction plaque disassembly and endocytosis in the cochlea. In Brain research bulletin, 174, 153-160. doi:10.1016/j.brainresbull.2021.06.008. https://pubmed.ncbi.nlm.nih.gov/34139316/
3. Chaudhary, Raushan Kumar, Patil, Prakash, Mateti, Uday Venkat, Alagundagi, Dhananjay B, Shetty, Vijith. 2023. Theranostic Potential of EFNB2 for Cetuximab Resistance in Head and Neck Cancer. In Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 75, 1923-1936. doi:10.1007/s12070-023-03739-9. https://pubmed.ncbi.nlm.nih.gov/37636764/
4. Xu, Chunjie, Gu, Lei, Kuerbanjiang, Manzila, Zhang, Zhigang, Xu, Qing. 2022. Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake. In Oncogene, 42, 99-112. doi:10.1038/s41388-022-02519-z. https://pubmed.ncbi.nlm.nih.gov/36376513/
5. Zhang, Qianshi, Li, Jing, Liu, Fubing, Zou, Jianfei, Wang, Xiaobin. 2024. Ephrin B2 (EFNB2) potentially protects against intervertebral disc degeneration through inhibiting nucleus pulposus cell apoptosis. In Archives of biochemistry and biophysics, 756, 109990. doi:10.1016/j.abb.2024.109990. https://pubmed.ncbi.nlm.nih.gov/38636690/
6. Zhu, Feng, Dai, Shang-Nan, Xu, Da-Lai, Wu, Jun-Li, Miao, Yi. 2020. EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 125, 109972. doi:10.1016/j.biopha.2020.109972. https://pubmed.ncbi.nlm.nih.gov/32036221/
7. Li, Dapeng, Sun, Anjiang, Zhang, Liang, Zha, Xiaojun, Liu, Yehai. 2022. Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2. In Theranostics, 12, 7431-7449. doi:10.7150/thno.76232. https://pubmed.ncbi.nlm.nih.gov/36438491/
8. Wang, Tingjie, Xu, Chuanrui, Zhang, Zhijing, Li, Lei, Ye, Kai. 2022. Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression. In Hepatology (Baltimore, Md.), 76, 1302-1317. doi:10.1002/hep.32483. https://pubmed.ncbi.nlm.nih.gov/35340039/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
